A survey published in the New England Journal of Medicine finds that physicians and nurse practitioners have different perspectives on their respective value to and place in the health system.
A new analysis published in Health Affairs suggests that the recent slowdown in national health spending growth may persist, as it appears to be due to factors other than just the economic downturn.
IMS released its annual report on use of prescription medicines and trends in the industry. The report finds that in 2012 both prescriptions and spending declined, which may be beneficial or may reflect underuse due to cost concerns.
A new paper from Rand looks at the effect of integrated care on a variety of outcomes, including provider and patient satisfaction, quality and costs.
An analysis of claims and other data from three Massachusetts health plans reveals that socioeconomic status seems to have little to do with relative physician costs of care.
The Brookings Institute issues another one of those “vision” pieces for the American health system. We need less vision and better analysis of and solutions for the real problems. All this vision is just impeding the clear sight of policymakers.
A report from the Employee Benefit Research Institute examines the characteristics of persons enrolled in consumer-driven and high-deductible health plans, which continue to show rapid growth.
An article published in Health Affairs uses the experience of several other countries to draw lessons for the development and operation of health insurance exchanges in the United States.
Proponents of health care coverage for years have suggested that people literally died without it. New research in regard to the Oregon Medicaid lottery suggests that is highly unlikely to be true and that insurance coverage has little to do with real health outcomes.
A new brief from the National Institute for Health Care Reform explores the status of hospital quality reporting efforts and makes recommendations for improvement.
Medscape has released the results of a survey of physician compensation, which shows it will increase in 2013 for most physicians, as it did in 2012.
The final post on the EMD Serono Specialty Digest covers oncology, an area which is seeing rapid growth in very expensive specialty compounds, and use of specialty pharmacy providers.
In the second part of our review of the EMD Serono Specialty Digest, we focus on utilization management.
The annual EMD Serono Specialty Digest is out and does the usual excellent job of describing trends in regard to the management and utilization of specialty pharmaceuticals.
Even after all the emphasis on guidelines and pay-for-performance the quality of care for diabetes patients has shown only very moderate improvement in the last ten years.